Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and death

被引:4
|
作者
Borg, Rikke [1 ,2 ]
Kriegbaum, Margit [3 ,4 ]
Grand, Mia Klinten [3 ,4 ]
Lind, Bent [5 ]
Andersen, Christen Lykkegaard [3 ,4 ,6 ]
Persson, Frederik [7 ]
机构
[1] Zealand Univ Hosp, Dept Med, Roskilde, Denmark
[2] Univ Copenhagen, Inst Clin Med, Copenhagen, Denmark
[3] Univ Copenhagen, Dept Publ Hlth, Res Unit Gen Practice, Copenhagen, Denmark
[4] Univ Copenhagen, Dept Publ Hlth, Sect Gen Practice, Copenhagen, Denmark
[5] Copenhagen Univ Hosp Hvidovre, Dept Clin Biochem, Hvidovre, Denmark
[6] Copenhagen Univ Hosp, Dept Hematol, Copenhagen, Denmark
[7] Steno Diabet Ctr Copenhagen, Herlev, Denmark
来源
BMC PRIMARY CARE | 2023年 / 24卷 / 01期
关键词
Chronic kidney disease; Primary care; eGFR; Kidney function; ESKD; HEART-FAILURE; CKD; OUTCOMES; MORTALITY;
D O I
10.1186/s12875-023-02077-7
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundThe prevalence of chronic kidney disease (CKD) is increasing globally. Early diagnosis in primary care may have a role in ensuring proper intervention. We aimed to determine the prevalence and outcome of CKD in primary care.MethodsWe performed an observational cohort study in primary care in Copenhagen (2001-2015). Outcomes were stroke, myocardial infarction (MI), heart failure (HF), peripheral artery disease (PAD), all-cause- and cardiovascular mortality. We combined individuals with normal kidney function and CKD stage 2 as reference. We conducted cause-specific Cox proportional regressions to calculate the hazard ratios for outcomes according to CKD group. We explored the associations between kidney function and the outcomes examined using eGFR as a continuous variable modelled with penalised splines. All models were adjusted for age, gender, diabetes, hypertension, existing CVD, heart failure, LDL cholesterol and use of antihypertensive treatment.ResultsWe included 171,133 individuals with at least two eGFR measurements of which the majority (n = 157,002) had eGFR > 60 ml/min/1.73m(2) at index date, and 0.05% were in CKD stage 5. Event rates were low in eGFR > 60 ml/min/1.73m(2) but increased in those with higher stages of CKD. In adjusted analyses we observed an increase in hazard rates for every outcome with every increment in CKD stage. Compared to the reference group, individuals in CKD stage 4 had double the hazard rate of PAD, MI, cardiovascular and all-cause mortality.ConclusionsOur data from a large primary care cohort demonstrate an early increase in the risk of adverse outcomes already at CKD stage 3. This underlines the importance of studying early intervention in primary care.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and death
    Rikke Borg
    Margit Kriegbaum
    Mia Klinten Grand
    Bent Lind
    Christen Lykkegaard Andersen
    Frederik Persson
    [J]. BMC Primary Care, 24
  • [2] Risk of End-Stage Renal Disease and Death After Cardiovascular Events in Chronic Kidney Disease
    Sud, Maneesh
    Tangri, Navdeep
    Pintilie, Melania
    Levey, Andrew S.
    Naimark, David
    [J]. CIRCULATION, 2014, 130 (06) : 458 - +
  • [3] Homelessness and Risk of End-Stage Kidney Disease and Death in Veterans With Chronic Kidney Disease
    Koyama, Alain K.
    Nee, Robert
    Yu, Wei
    Choudhury, Devasmita
    Heng, Fei
    Cheung, Alfred K.
    Cho, Monique E.
    Norris, Keith C.
    Yan, Guofen
    [J]. JAMA NETWORK OPEN, 2024, 7 (09)
  • [4] Infection in advanced chronic kidney disease leads to increased risk of cardiovascular events, end-stage kidney-disease and mortality
    Hassan, Hicham I. Cheikh
    Tang, Mila
    Djurdjev, Ognjenka
    Langsford, David
    Sood, Manish M.
    Levin, Adeera
    [J]. KIDNEY INTERNATIONAL, 2016, 90 (04) : 897 - 904
  • [5] Chronic Kidney Disease and the Risk of End-Stage Renal Disease versus Death
    Dalrymple, Lorien S.
    Katz, Ronit
    Kestenbaum, Bryan
    Shlipak, Michael G.
    Sarnak, Mark J.
    Stehman-Breen, Catherine
    Seliger, Stephen
    Siscovick, David
    Newman, Anne B.
    Fried, Linda
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 (04) : 379 - 385
  • [6] Chronic Kidney Disease and the Risk of End-Stage Renal Disease versus Death
    Lorien S. Dalrymple
    Ronit Katz
    Bryan Kestenbaum
    Michael G. Shlipak
    Mark J. Sarnak
    Catherine Stehman-Breen
    Stephen Seliger
    David Siscovick
    Anne B. Newman
    Linda Fried
    [J]. Journal of General Internal Medicine, 2011, 26 : 379 - 385
  • [7] Chronic kidney disease and risk of mortality, cardiovascular events or end-stage renal disease in older patients with hypertension
    Gentile, Giorgio
    Trillini, Matias
    [J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2012, 10 (10) : 1213 - 1216
  • [8] CHRONIC KIDNEY DISEASE IN PRIMARY CARE AND THE RISK OF CARDIOVASCULAR COMORBIDITY AND MORTALITY
    Borg, Rikke
    Kriegbaum, Margit
    Grand, Mia Klinten
    Lind, Bent Struer
    Andersen, Christen Lykkegaard
    Persson, Frederik
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I375 - I376
  • [9] Anemia and cardiovascular disease, hospitalization, end stage renal disease, and death in older patients with chronic kidney disease
    Li S.
    Foley R.N.
    Collins A.J.
    [J]. International Urology and Nephrology, 2005, 37 (2) : 395 - 402
  • [10] Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
    Go, AS
    Chertow, GM
    Fan, DJ
    McCulloch, CE
    Hsu, CY
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (13): : 1296 - 1305